Trial Outcomes & Findings for Validation of Noninvasive Hemoglobin, Comparison of PVI to Standard Methods, and Validation of Clinical Efficacy of ORI (NCT NCT02841397)

NCT ID: NCT02841397

Last Updated: 2021-10-21

Results Overview

Accuracy of SpHb will be determined by comparing it to the hemoglobin value obtained from a reference blood sample and calculating the accuracy root mean square (Arms) error value. In order to obtain the Arms value, the blood sample hemoglobin value is subtracted from SpHb value for a number of samples, the average of this difference is computed as the bias. The standard deviation of the differences is computed as the precision. The square root of the sum of the squares of bias and precision is computed as the Arms Error value.

Recruitment status

COMPLETED

Target enrollment

50 participants

Primary outcome timeframe

Duration of study participation is up to three days.

Results posted on

2021-10-21

Participant Flow

Participant milestones

Participant milestones
Measure
Test Group
All subjects will be enrolled into the test group and will receive Masimo Pulse CO-Oximeter for measurement of various physiological parameters. Masimo Pulse CO-Oximeter: Noninvasive pulse oximeter with various features for measurement of hemoglobin, pleth variability index, and oxygen reserve index
Overall Study
STARTED
50
Overall Study
COMPLETED
48
Overall Study
NOT COMPLETED
2

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

There were four subjects that did not complete the study.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Test Group
n=50 Participants
All subjects will be enrolled into the test group and will receive Masimo Pulse CO-Oximeter for measurement of various physiological parameters. Masimo Pulse CO-Oximeter: Noninvasive pulse oximeter with various features for measurement of hemoglobin, pleth variability index, and oxygen reserve index
Age, Categorical
<=18 years
1 Participants
n=48 Participants • There were four subjects that did not complete the study.
Age, Categorical
Between 18 and 65 years
30 Participants
n=48 Participants • There were four subjects that did not complete the study.
Age, Categorical
>=65 years
17 Participants
n=48 Participants • There were four subjects that did not complete the study.
Sex: Female, Male
Female
26 Participants
n=48 Participants • Please see reasons provided above.
Sex: Female, Male
Male
22 Participants
n=48 Participants • Please see reasons provided above.
Region of Enrollment
United States
48 participants
n=48 Participants • Please see reasoning above.

PRIMARY outcome

Timeframe: Duration of study participation is up to three days.

Population: A total of 12 subjects were excluded from data analysis Subjects were excluded from data analysis for different reasons. Reason 1: Blood sample could not be analyzed because received out of analyzer required time window Reason 2: Sensor data is not available Reason 3: No time matched sensor and blood sample data pair for analysis Reason 4: Reference tHb error. tHb difference \>1g/dL between different methods

Accuracy of SpHb will be determined by comparing it to the hemoglobin value obtained from a reference blood sample and calculating the accuracy root mean square (Arms) error value. In order to obtain the Arms value, the blood sample hemoglobin value is subtracted from SpHb value for a number of samples, the average of this difference is computed as the bias. The standard deviation of the differences is computed as the precision. The square root of the sum of the squares of bias and precision is computed as the Arms Error value.

Outcome measures

Outcome measures
Measure
Test Group
n=34 Participants
All subjects will be enrolled into the test group and will receive Masimo Pulse CO-Oximeter for measurement of various physiological parameters. Masimo Pulse CO-Oximeter: Noninvasive pulse oximeter with various features for measurement of hemoglobin, pleth variability index, and oxygen reserve index
Noninvasive Pulse Oximetry-determined SpHb Bias
0.9 g/dL

PRIMARY outcome

Timeframe: Duration of study participation is up to three days.

Population: There was no reference SVV or PPV data available for PVI data analysis.

Correlation of PVI measurement compared with pulse pressure variation PPV or stroke volume variation (SVV) measurement from arterial catheter

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: Duration of study participation is up to three days.

Population: Data from 8 subjects were obtained. At least two samples per subject are required to compare ORI trending ability; however, only 1 sample was obtained from each subject which precluded conduct of any data analysis.

Concordance will be determined by comparing the trending ability of the Oxygen Reserve Index (ORI) measurement of the sensor with that of Partial Pressure of Oxygen in Blood (PaO2).

Outcome measures

Outcome data not reported

Adverse Events

Test Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Cristina Johnson

Masimo Corporation

Phone: (949) 297-7000

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place

Restriction type: GT60